CancerX is a public-private partnership announced by The White House as a national accelerator to boost innovation in the fight against cancer as part of the reignited Cancer Moonshot.
Co-hosted by Moffitt Cancer Center and Digital Medicine Society (DiMe), we convene the many diverse stakeholders needed to unleash the power of innovation to fight cancer.
The United States’ Cancer Problem
1,958,310
new cancer cases predicted for 2023.
609,820
cancer deaths predicted for 2023.
2nd
leading cause of deaths in the U.S.
Cancer survivors are
2.5x
more likely to declare bankruptcy
CancerX is open to all those working in the field who share our vision and are committed to working collaboratively to achieve it. Please complete the form to learn more.
Work is Already Underway!
Advancing Digital Innovation to Improve Equity and Reduce Financial Toxicity in Cancer Care and Research.
CancerX in the news
ViVe 2023: CancerX co-hosts Moffitt Cancer Center, Digital Medicine Society unveil 'Moonshot' digital health effort
Moffitt Cancer Center and DiMe to Co-Host Cancer Moonshot’s New CancerX Public-Private Partnership
Moffitt Cancer Center, Digital Medicine Society partner on 'Moonshot' digital health initiative
Moffitt Cancer Center, Digital Medicine Society partner on 'Moonshot' digital health initiative
Folia Health joins the Cancer Moonshot’s CancerX Public-Private Partnership as a Founding Member
PAVmed Digital Health Subsidiary, Veris Health, Joins Cancer Moonshot's CancerX Partnership as Founding Member
Thyme Care Joins CancerX Innovation Accelerator as Founding Member to Ignite Cancer Moonshot
Stay in the Loop
Be the first to know when these resources launch.
